Authors
Latest:
When to implant phakic IOLsPhakic IOL implantation offers a number of benefits for patients with myopia who are not candidates for laser vision correction.
Latest:
Key Retreatment Decisions in the Clinical Trials for Faricimab in nAMDDr Varun Chaudhary presents the retreatment decisions during the treat-and-extend phase of the TENAYA and LUCERNE clinical trials in neovascular AMD, focusing on the percentage of patients who maintained, extended, or reduced their treatment interval based on visual and anatomic criteria.
Latest:
Dry AMD: A review of ongoing, completed and future treatmentsThe most promising recent interventional trials for investigational therapies in dry age-related macular degeneration are highlighted by the authors.
Latest:
Artificial intelligence as patient resource: findings from a chatbot investigationOphthalmologists graded AI bots' answers to questions from patients following cataract surgery
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
The significance of FLIO in diabetic eye diseasePreliminary analysis of FLIO data using artificial intelligence suggests potential novel biomarkers
Latest:
Diabetic eye disease: Where are we now?Clinicians must consider redefining the metrics and intention behind functional outcomes, according to experts from the European Association for the Study of Diabetic Eye Complications
Latest:
New technologies improve retinal care, managing patient expectations is keyRetina specialists and their patients have learned how AI and telemedicine can be effective in monitoring disease progression and alerting clinicians to early signs of adverse changes.
Latest:
Let’s throw everything away…except the patient and the surgeonSingle-use cataract surgery comes with several safety and quality attributes.
Latest:
Bringing biologics to eye health: Regenerative medicine for inflammatory disordersBiologic treatments can be utilised to help the eye heal itself in inflammatory conditions such as dry eye disorder.
Latest:
Managing small pupil challenges in patients with the Malyugin ringThe Malyugin ring 2.0 expands the small pupil safely and effectively to enable excellent intraoperative visualisation. It has a good safety record and is easier to use than alternative methods.
Latest:
Ophthalmologist shares his Holocaust survivor storyAs the world observes International Holocaust Remembrance Day each January 27, Dr John H. Merey may be the only Holocaust survivor still in the practice of ophthalmology.
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
How remote retinal imaging raises the bar across service, research and educationProf Baljean Dhillon advocated for remote practices and provided advice for implementation at the International SPECTRALIS Symposium
Latest:
Efficacy and Safety of Aflibercept 8 mg in PHOTON Trial in DMODr. Marion Munk examines the Phase 2/3 clinical trial of high-dose aflibercept (8 mg) in diabetic macular oedema, presenting key outcomes and clinical implications of the data.
Latest:
Mastering the Yamane technique: Key learnings from first casesPractice makes perfect when adopting this method for intrascleral IOL fixation.
Latest:
A closer look at how cell therapy for corneal endothelial disease is gaining tractionGround-breaking treatment for bullous keratopathy approved in Japan
Latest:
Seize under-utilised opportunity to treat glaucoma during vitrectomyCombining ECP with vitrectomy can reduce medication use following the procedure and in some cases avoid the need for further surgery.
Latest:
Study targets strategies for CI-DMOIn the DRCR Retina Network Protocol V, which studied management strategies for eyes with centre-involving DMO and good visual acuity, the majority of eyes randomly assigned to initial observation completed the 2-year study without needing anti-VEGF therapy for vision loss and nearly one-third had spontaneous resolution of DMO.
Latest:
Considering antibiotics use in postoperative endophthalmitisWhilst endophthalmitis following cataract surgery can lead to serious vision outcomes, there are ways of minimising the risk of it occurring whilst also being mindful of the need to prescribe antibiotics in a way that does not worsen antimicrobial resistance.
Latest:
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS SymposiumHigh-resolution optical coherence tomography illuminates crucial biomarkers in age-related macular degeneration, Dr Sadda said
Latest:
Successful treatment of bilateral diffuse uveal melanocytic proliferation with plasmapheresisIn this case study, a patient with recently diagnosed cancer demonstrated significant improvement for ocular symptoms of BDUMP following plasmapheresis
Latest:
Balancing the promises and challenges of artificial intelligenceSophisticated programmes require an evolving mindset
Latest:
Long-duration spaceflight tests the limits of telemedicineIn-orbit imaging drives innovation in terrestrial telemedicine, the NASA scientist explained
Latest:
Shifting the narrative around dry eye diseaseA qualitative study method illuminates patients’ fears for the future
Latest:
IOL design puts a new spin on visionAdvancements in lens technology reflect the growing popularity of multifocal lenses
